{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:47:08Z","timestamp":1791229628539,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T00:00:00Z","timestamp":1654128000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T00:00:00Z","timestamp":1654128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Shuhua Zhang","award":["No. 20192BAB205007"],"award-info":[{"award-number":["No. 20192BAB205007"]}]},{"name":"Shuhua Zhang","award":["No. 20192BAB205007"],"award-info":[{"award-number":["No. 20192BAB205007"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Hypertriglyceridemic-waist (HTGW) phenotype has been proposed as a practical tool for screening the risk of cardiovascular diseases and glycemic metabolic disease. This study sought to investigate the relationship between HTGW phenotype and non-alcoholic fatty liver disease (NAFLD).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A total of 14,251 subjects who took part in health screening were enrolled in the study and NAFLD was diagnosed by abdominal ultrasound. According to triglyceride (TG) and waist circumference, the study population was divided into four phenotypes, in which HTGW phenotype was defined as TG\u2009\u2265\u20091.7\u2009mmol\/L and male waist circumference\u2009\u2265\u200990\u2009cm or female waist circumference\u2009\u2265\u200980\u2009cm. Multivariate logistic regression analysis was used to evaluate the relationship between HTGW phenotype and NAFLD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In the current study, 2.43% of the subjects had HTGW phenotype, while the prevalence of NAFLD in subjects with HTGW phenotype was 77.81%. After full adjustment for covariates, compared with people with normal waist circumference and TG levels, the risk of NAFLD in people with normal TG levels but enlarged waist circumference increased by 39% [OR:1.39, 95%CI: 1.15, 1.68], in people with normal waist circumference but elevated TG levels increased by 96% [OR:1.96, 95%CI: 1.65, 2.33], and in subjects with HTGW phenotype increased by 160% [OR:2.60, 95%CI: 1.88, 3.58]. Additionally, further analysis suggested that there were significant interactions between age, height, BMI and NAFLD risk associated with TGW phenotypes. Receiver operating characteristic curves analysis suggested that the combination of TG and waist circumference further improved the diagnostic value for NAFLD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>HTGW phenotype is associated with NAFLD risk in the general population, which may be a novel and accessible indicator for NAFLD screening.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12944-022-01660-8","type":"journal-article","created":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T11:06:55Z","timestamp":1654168015000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Association between hypertriglyceridemic-waist phenotype and non-alcoholic fatty liver disease: a general population-based study"],"prefix":"10.1186","volume":"21","author":[{"given":"Ming","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maobin","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,2]]},"reference":[{"key":"1660_CR1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12916-017-0806-8","volume":"15","author":"BA Neuschwander-Tetri","year":"2017","unstructured":"Neuschwander-Tetri BA. Non-alcoholic fatty liver disease. BMC Med. 2017;15:45.","journal-title":"BMC Med"},{"key":"1660_CR2","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.4155\/fmc-2019-0003","volume":"11","author":"S Ballestri","year":"2019","unstructured":"Ballestri S, Mantovani A, Nascimbeni F, Lugari S, Lonardo A. Extra-hepatic manifestations and complications of nonalcoholic fatty liver disease. Future Med Chem. 2019;11:2171\u201392.","journal-title":"Future Med Chem"},{"key":"1660_CR3","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","volume":"62","author":"CD Byrne","year":"2015","unstructured":"Byrne CD, Targher G. NAFLD: a multisystem disease. J Hepatol. 2015;62:S47\u201364.","journal-title":"J Hepatol"},{"key":"1660_CR4","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","volume":"70","author":"ZM Younossi","year":"2019","unstructured":"Younossi ZM. Non-alcoholic fatty liver disease - a global public health perspective. J Hepatol. 2019;70:531\u201344.","journal-title":"J Hepatol"},{"key":"1660_CR5","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64:73\u201384.","journal-title":"Hepatology"},{"key":"1660_CR6","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.1097\/MCG.0000000000000075","volume":"49","author":"AC Wieland","year":"2015","unstructured":"Wieland AC, Mettler P, McDermott MT, Crane LA, Cicutto LC, Bambha KM. Low awareness of nonalcoholic fatty liver disease among patients at high metabolic risk. J Clin Gastroenterol. 2015;49:e6\u2013e10.","journal-title":"J Clin Gastroenterol"},{"key":"1660_CR7","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1002\/hep4.1765","volume":"5","author":"SA Alqahtani","year":"2021","unstructured":"Alqahtani SA, Paik JM, Biswas R, Arshad T, Henry L, Younossi ZM. Poor awareness of liver disease among adults with NAFLD in the United States. Hepatol Commun. 2021;5:1833\u201347.","journal-title":"Hepatol Commun"},{"key":"1660_CR8","doi-asserted-by":"publisher","first-page":"e0215636","DOI":"10.1371\/journal.pone.0215636","volume":"14","author":"MM Bikbov","year":"2019","unstructured":"Bikbov MM, Fayzrakhmanov RR, Kazakbaeva GM, Zainullin RM, Arslangareeva II, Gilmanshin TR, et al. Prevalence, awareness and control of diabetes in Russia: the Ural eye and medical study on adults aged 40+ years. PLoS One. 2019;14:e0215636.","journal-title":"PLoS One"},{"key":"1660_CR9","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1001\/jama.2013.168118","volume":"310","author":"Y Xu","year":"2013","unstructured":"Xu Y, Wang L, He J, Bi Y, Li M, Wang T, et al. Prevalence and control of diabetes in Chinese adults. JAMA. 2013;310:948\u201359.","journal-title":"JAMA"},{"key":"1660_CR10","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1001\/jama.2015.10029","volume":"314","author":"A Menke","year":"2015","unstructured":"Menke A, Casagrande S, Geiss L, Cowie CC. Prevalence of and trends in diabetes among adults in the United States, 1988-2012. JAMA. 2015;314:1021\u20139.","journal-title":"JAMA"},{"key":"1660_CR11","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1161\/CIRCULATIONAHA.115.018912","volume":"134","author":"KT Mills","year":"2016","unstructured":"Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, et al. Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Circulation. 2016;134:441\u201350.","journal-title":"Circulation"},{"key":"1660_CR12","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41575-021-00523-4","volume":"19","author":"JV Lazarus","year":"2022","unstructured":"Lazarus JV, Mark HE, Anstee QM, Arab JP, Batterham RL, Castera L, et al. Advancing the global public health agenda for NAFLD: a consensus statement. Nat Rev Gastroenterol Hepatol. 2022;19:60\u201378.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1660_CR13","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1161\/01.CIR.102.2.179","volume":"102","author":"I Lemieux","year":"2000","unstructured":"Lemieux I, Pascot A, Couillard C, Lamarche B, Tchernof A, Alm\u00e9ras N, et al. Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? Circulation. 2000;102:179\u201384.","journal-title":"Circulation"},{"key":"1660_CR14","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12944-019-1019-2","volume":"18","author":"Y Ding","year":"2019","unstructured":"Ding Y, Zhang M, Wang L, Yin T, Wang N, Wu J, et al. Association of the hypertriglyceridemic waist phenotype and severity of acute pancreatitis. Lipids Health Dis. 2019;18:93.","journal-title":"Lipids Health Dis"},{"key":"1660_CR15","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/ijo.2010.127","volume":"35","author":"R Gomez-Huelgas","year":"2011","unstructured":"Gomez-Huelgas R, Bernal-L\u00f3pez MR, Villalobos A, Mancera-Romero J, Baca-Osorio AJ, Jansen S, et al. Hypertriglyceridemic waist: an alternative to the metabolic syndrome? Results of the IMAP study (multidisciplinary intervention in primary care). Int J Obes. 2011;35:292\u20139.","journal-title":"Int J Obes"},{"key":"1660_CR16","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1111\/jdi.12489","volume":"7","author":"Y Ren","year":"2016","unstructured":"Ren Y, Zhang M, Zhao J, Wang C, Luo X, Zhang J, et al. Association of the hypertriglyceridemic waist phenotype and type 2 diabetes mellitus among adults in China. J Diabetes Investig. 2016;7:689\u201394.","journal-title":"J Diabetes Investig"},{"key":"1660_CR17","first-page":"1031939","volume":"2018","author":"K Zhao","year":"2018","unstructured":"Zhao K, Yang SS, Wang HB, Chen K, Lu ZH, Mu YM. Association between the Hypertriglyceridemic waist phenotype and prediabetes in Chinese adults aged 40 years and older. J Diabetes Res. 2018;2018:1031939.","journal-title":"J Diabetes Res"},{"key":"1660_CR18","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1007\/s10067-017-3559-z","volume":"36","author":"S Chen","year":"2017","unstructured":"Chen S, Guo X, Dong S, Yu S, Chen Y, Zhang N, et al. Association between the hypertriglyceridemic waist phenotype and hyperuricemia: a cross-sectional study. Clin Rheumatol. 2017;36:1111\u20139.","journal-title":"Clin Rheumatol"},{"key":"1660_CR19","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/ane.12925","volume":"138","author":"W Wang","year":"2018","unstructured":"Wang W, Shen C, Zhao H, Tang W, Yang S, Li J, et al. A prospective study of the hypertriglyceridemic waist phenotype and risk of incident ischemic stroke in a Chinese rural population. Acta Neurol Scand. 2018;138:156\u201362.","journal-title":"Acta Neurol Scand"},{"key":"1660_CR20","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.3390\/ijerph13121233","volume":"13","author":"J Zeng","year":"2016","unstructured":"Zeng J, Liu M, Wu L, Wang J, Yang S, Wang Y, et al. The Association of Hypertriglyceridemic Waist Phenotype with chronic kidney disease and its sex difference: a cross-sectional study in an urban Chinese elderly population. Int J Environ Res Public Health. 2016;13:1233.","journal-title":"Int J Environ Res Public Health"},{"key":"1660_CR21","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1007\/s40519-019-00677-w","volume":"25","author":"YM Tian","year":"2020","unstructured":"Tian YM, Ma N, Jia XJ, Lu Q. The \u201chyper-triglyceridemic waist phenotype\u201d is a reliable marker for prediction of accumulation of abdominal visceral fat in Chinese adults. Eat Weight Disord. 2020;25:719\u201326.","journal-title":"Eat Weight Disord"},{"key":"1660_CR22","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.metabol.2009.03.012","volume":"58","author":"P Blackburn","year":"2009","unstructured":"Blackburn P, Lemieux I, Alm\u00e9ras N, Bergeron J, C\u00f4t\u00e9 M, Tremblay A, et al. The hypertriglyceridemic waist phenotype versus the National Cholesterol Education Program-Adult Treatment Panel III and international diabetes federation clinical criteria to identify high-risk men with an altered cardiometabolic risk profile. Metabolism. 2009;58:1123\u201330.","journal-title":"Metabolism"},{"key":"1660_CR23","first-page":"181","volume":"21","author":"SM Hosseini","year":"2011","unstructured":"Hosseini SM, Mousavi S, Poursafa P, Kelishadi R. Risk score model for predicting sonographic non-alcoholic fatty liver disease in children and adolescents. Iran J Pediatr. 2011;21:181\u20137.","journal-title":"Iran J Pediatr"},{"key":"1660_CR24","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.2147\/DMSO.S302297","volume":"14","author":"PJ Liu","year":"2021","unstructured":"Liu PJ, Lou HP, Zhu YN. Identification of hepatic steatosis in premenopausal and postmenopausal women based on phenotypes combining triglyceride levels and anthropometric indices: a cross-sectional study. Diabetes Metab Syndr Obes. 2021;14:1339\u201347.","journal-title":"Diabetes Metab Syndr Obes"},{"key":"1660_CR25","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1038\/s41598-021-00825-2","volume":"12","author":"M Zhou","year":"2022","unstructured":"Zhou M, Li F, Tang H, Wu S, Meng L, Dong Y, et al. The hypertriglyceridemic waist phenotype is associated with fatty liver and glycometabolic profiles in overweight and obese adults: a cross-sectional study. Sci Rep. 2022;12:2410.","journal-title":"Sci Rep"},{"key":"1660_CR26","doi-asserted-by":"publisher","DOI":"10.5061\/dryad.8q0p192","volume-title":"Data from: ectopic fat obesity presents the greatest risk for incident type 2 diabetes: a population-based longitudinal study, Dryad, Dataset","author":"T Okamura","year":"2019","unstructured":"Okamura T, et al. Data from: ectopic fat obesity presents the greatest risk for incident type 2 diabetes: a population-based longitudinal study, Dryad, Dataset; 2019. https:\/\/doi.org\/10.5061\/dryad.8q0p192."},{"key":"1660_CR27","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41366-018-0076-3","volume":"43","author":"T Okamura","year":"2019","unstructured":"Okamura T, Hashimoto Y, Hamaguchi M, Obora A, Kojima T, Fukui M. Ectopic fat obesity presents the greatest risk for incident type 2 diabetes: a population-based longitudinal study. Int J Obes. 2019;43:139\u201348.","journal-title":"Int J Obes"},{"key":"1660_CR28","doi-asserted-by":"publisher","first-page":"662","DOI":"10.3350\/cmh.2020.0163","volume":"26","author":"JH Choi","year":"2020","unstructured":"Choi JH, Sohn W, Cho YK. The effect of moderate alcohol drinking in nonalcoholic fatty liver disease. Clin Mol Hepatol. 2020;26:662\u20139.","journal-title":"Clin Mol Hepatol"},{"key":"1660_CR29","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1111\/j.1572-0241.2007.01526.x","volume":"102","author":"M Hamaguchi","year":"2007","unstructured":"Hamaguchi M, Kojima T, Itoh Y, Harano Y, Fujii K, Nakajima T, et al. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am J Gastroenterol Am J Gastroenterol. 2007;102:2708\u201315.","journal-title":"Am J Gastroenterol Am J Gastroenterol"},{"key":"1660_CR30","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.2337\/dc18-S002","volume":"41","author":"American Diabetes Association","year":"2018","unstructured":"American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2018. Diabetes Care. 2018;41:S13\u201327.","journal-title":"Diabetes Care"},{"key":"1660_CR31","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1002\/sim.4780111003","volume":"11","author":"Y Wax","year":"1992","unstructured":"Wax Y. Collinearity diagnosis for a relative risk regression analysis: an application to assessment of diet-cancer relationship in epidemiological studies. Stat Med. 1992;11:1273\u201387.","journal-title":"Stat Med"},{"key":"1660_CR32","doi-asserted-by":"publisher","first-page":"e202","DOI":"10.1016\/S1473-3099(16)30082-2","volume":"16","author":"EJA Fitchett","year":"2016","unstructured":"Fitchett EJA, Seale AC, Vergnano S, Sharland M, Heath PT, Saha SK, et al. Strengthening the reporting of observational studies in epidemiology for newborn infection (STROBE-NI): an extension of the STROBE statement for neonatal infection research. Lancet Infect Dis. 2016;16:e202\u201313.","journal-title":"Lancet Infect Dis"},{"key":"1660_CR33","doi-asserted-by":"publisher","first-page":"27034","DOI":"10.1038\/srep27034","volume":"6","author":"KC Yang","year":"2016","unstructured":"Yang KC, Hung HF, Lu CW, Chang HH, Lee LT, Huang KC. Association of non-alcoholic Fatty Liver Disease with metabolic syndrome independently of central obesity and insulin resistance. Sci Rep. 2016;6:27034.","journal-title":"Sci Rep"},{"key":"1660_CR34","doi-asserted-by":"publisher","first-page":"1838679","DOI":"10.1155\/2017\/1838679","volume":"2017","author":"AA Paiva","year":"2017","unstructured":"Paiva AA, Raposo HF, Wanschel AC, Nardelli TR, Oliveira HC. Apolipoprotein CIII overexpression-induced hypertriglyceridemia increases nonalcoholic fatty liver disease in association with inflammation and cell death. Oxidative Med Cell Longev. 2017;2017:1838679.","journal-title":"Oxidative Med Cell Longev"},{"key":"1660_CR35","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1016\/j.cgh.2015.07.029","volume":"13","author":"A Ahmed","year":"2015","unstructured":"Ahmed A, Wong RJ, Harrison SA. Nonalcoholic fatty liver disease review: diagnosis, treatment, and outcomes. Clin Gastroenterol Hepatol. 2015;13:2062\u201370.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1660_CR36","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/nature05488","volume":"444","author":"JP Despr\u00e9s","year":"2006","unstructured":"Despr\u00e9s JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006;444:881\u20137.","journal-title":"Nature"},{"key":"1660_CR37","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.metabol.2010.03.006","volume":"60","author":"SC Kalhan","year":"2011","unstructured":"Kalhan SC, Guo L, Edmison J, Dasarathy S, McCullough AJ, Hanson RW, et al. Plasma metabolomic profile in nonalcoholic fatty liver disease. Metabolism. 2011;60:404\u201313.","journal-title":"Metabolism"},{"key":"1660_CR38","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.mce.2016.12.022","volume":"455","author":"Z Gong","year":"2017","unstructured":"Gong Z, Tas E, Yakar S, Muzumdar R. Hepatic lipid metabolism and non-alcoholic fatty liver disease in aging. Mol Cell Endocrinol. 2017;455:115\u201330.","journal-title":"Mol Cell Endocrinol"},{"key":"1660_CR39","first-page":"443","volume":"102","author":"J Vangipurapu","year":"2017","unstructured":"Vangipurapu J, Stanc\u00e1kov\u00e1 A, Jauhiainen R, Kuusisto J, Laakso M. Short adult stature predicts impaired \u03b2-cell function, insulin resistance, Glycemia, and type 2 diabetes in Finnish men. J Clin Endocrinol Metab. 2017;102:443\u201350.","journal-title":"J Clin Endocrinol Metab"},{"key":"1660_CR40","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s10903-014-9985-y","volume":"18","author":"MV D\u00edaz-Santana","year":"2016","unstructured":"D\u00edaz-Santana MV, Su\u00e1rez P\u00e9rez EL, Ortiz Mart\u00ednez AP, Guzm\u00e1n Serrano M, P\u00e9rez Cardona CM. Association between the Hypertriglyceridemic waist phenotype, prediabetes, and diabetes mellitus among adults in Puerto Rico. J Immigr Minor Health. 2016;18:102\u20139.","journal-title":"J Immigr Minor Health"},{"key":"1660_CR41","doi-asserted-by":"publisher","first-page":"368","DOI":"10.3390\/ijerph13040368","volume":"13","author":"S Chen","year":"2016","unstructured":"Chen S, Guo X, Yu S, Sun G, Li Z, Sun Y. Association between the Hypertriglyceridemic waist phenotype, prediabetes, and diabetes mellitus in rural Chinese population: a cross-sectional study. Int J Environ Res Public Health. 2016;13:368.","journal-title":"Int J Environ Res Public Health"},{"key":"1660_CR42","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1017\/S1368980019000181","volume":"22","author":"YC Ren","year":"2019","unstructured":"Ren YC, Liu Y, Sun XZ, Wang BY, Liu Y, Ni H, et al. Prevalence and relationship of hypertriglyceridaemic-waist phenotype and type 2 diabetes mellitus among a rural adult Chinese population. Public Health Nutr. 2019;22:1361\u20136.","journal-title":"Public Health Nutr"},{"key":"1660_CR43","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.orcp.2016.11.003","volume":"11","author":"A Ramezankhani","year":"2017","unstructured":"Ramezankhani A, Azizi F, Ghanbarian A, Parizadeh D, Hadaegh F. The hypertriglyceridemic waist and waist-to-height ratio phenotypes and chronic kidney disease: cross-sectional and prospective investigations. Obes Res Clin Pract. 2017;11:585\u201396.","journal-title":"Obes Res Clin Pract"},{"key":"1660_CR44","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1080\/07420528.2018.1563094","volume":"36","author":"DM McMahon","year":"2019","unstructured":"McMahon DM, Burch JB, Youngstedt SD, Wirth MD, Hardin JW, Hurley TG, et al. Relationships between chronotype, social jetlag, sleep, obesity and blood pressure in healthy young adults. Chronobiol Int. 2019;36:493\u2013509.","journal-title":"Chronobiol Int"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-022-01660-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-022-01660-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-022-01660-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T12:07:25Z","timestamp":1654171645000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-022-01660-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,2]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1660"],"URL":"https:\/\/doi.org\/10.1186\/s12944-022-01660-8","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,2]]},"assertion":[{"value":"4 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent for data use has been described in previous studies with the subject\u2019s own authorization. Additionally, the current research protocol has been approved by the Institutional Review Committee of Jiangxi Provincial People\u2019s Hospital (review No: 2021\u2013066), and the entire research process follows the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors have no conflicts of interest to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"50"}}